BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 33720688)

  • 1. Antisense RNA Interference-Enhanced CRISPR/Cas9 Base Editing Method for Improving Base Editing Efficiency in
    Zhang Y; Yun K; Huang H; Tu R; Hua E; Wang M
    ACS Synth Biol; 2021 May; 10(5):1053-1063. PubMed ID: 33720688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex genome editing using a dCas9-cytidine deaminase fusion in Streptomyces.
    Zhao Y; Tian J; Zheng G; Chen J; Sun C; Yang Z; Zimin AA; Jiang W; Deng Z; Wang Z; Lu Y
    Sci China Life Sci; 2020 Jul; 63(7):1053-1062. PubMed ID: 31872379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in
    Yu S; Price MA; Wang Y; Liu Y; Guo Y; Ni X; Rosser SJ; Bi C; Wang M
    ACS Synth Biol; 2020 Jul; 9(7):1781-1789. PubMed ID: 32551562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
    Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytosine base editing in cyanobacteria by repressing archaic Type IV uracil-DNA glycosylase.
    Lee M; Heo YB; Woo HM
    Plant J; 2023 Feb; 113(3):610-625. PubMed ID: 36565011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
    Komor AC; Kim YB; Packer MS; Zuris JA; Liu DR
    Nature; 2016 May; 533(7603):420-4. PubMed ID: 27096365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces.
    Huang H; Zheng G; Jiang W; Hu H; Lu Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):231-43. PubMed ID: 25739462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-tuning the regulation of Cas9 expression levels for efficient CRISPR-Cas9 mediated recombination in Streptomyces.
    Ye S; Enghiad B; Zhao H; Takano E
    J Ind Microbiol Biotechnol; 2020 May; 47(4-5):413-423. PubMed ID: 32367443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex Gene Disruption by Targeted Base Editing of Yarrowia lipolytica Genome Using Cytidine Deaminase Combined with the CRISPR/Cas9 System.
    Bae SJ; Park BG; Kim BG; Hahn JS
    Biotechnol J; 2020 Jan; 15(1):e1900238. PubMed ID: 31657874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAS9 is a genome mutator by directly disrupting DNA-PK dependent DNA repair pathway.
    Xu S; Kim J; Tang Q; Chen Q; Liu J; Xu Y; Fu X
    Protein Cell; 2020 May; 11(5):352-365. PubMed ID: 32170574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient DSB-free base editing for streptomycetes with CRISPR-BEST.
    Tong Y; Whitford CM; Robertsen HL; Blin K; Jørgensen TS; Klitgaard AK; Gren T; Jiang X; Weber T; Lee SY
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20366-20375. PubMed ID: 31548381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Efficiency Genome Editing of Streptomyces Species by an Engineered CRISPR/Cas System.
    Wang Y; Cobb RE; Zhao H
    Methods Enzymol; 2016; 575():271-84. PubMed ID: 27417933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a CRISPR/Cas9
    Ma JX; He WY; Hua HM; Zhu Q; Zheng GS; Zimin AA; Wang WF; Lu YH
    ACS Synth Biol; 2023 Oct; 12(10):3114-3123. PubMed ID: 37722085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycosylase base editors enable C-to-A and C-to-G base changes.
    Zhao D; Li J; Li S; Xin X; Hu M; Price MA; Rosser SJ; Bi C; Zhang X
    Nat Biotechnol; 2021 Jan; 39(1):35-40. PubMed ID: 32690970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase.
    Tong H; Wang H; Wang X; Liu N; Li G; Wu D; Li Y; Jin M; Li H; Wei Y; Li T; Yuan Y; Shi L; Yao X; Zhou Y; Yang H
    Nat Commun; 2024 Jun; 15(1):4897. PubMed ID: 38851742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Base Editing with CRISPR-Deaminase in Tomato.
    Shimatani Z; Ariizumi T; Fujikura U; Kondo A; Ezura H; Nishida K
    Methods Mol Biol; 2019; 1917():297-307. PubMed ID: 30610645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9
    Li Q; Seys FM; Minton NP; Yang J; Jiang Y; Jiang W; Yang S
    Biotechnol Bioeng; 2019 Jun; 116(6):1475-1483. PubMed ID: 30739328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.